[{"orgOrder":0,"company":"Ichnos Glenmark Innovation","sponsor":"Certara","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Certara and Ichnos Glenmark Collaborate On Cancer Drug Dosing Optimization","therapeuticArea":"Oncology","highestDevelopmentStatus":"Phase I","country":"","productType":"Large molecule","productStatus":"New Molecular Entity","date":"September 2024","year":"2024","type":"Collaboration","leadProduct":"ISB 2001","moa":"","url1":"","url2":"","graph1":null,"graph2":null,"graph3":"Ichnos Glenmark Innovation","amount2":0,"therapeuticAreaNew":null,"highestDevelopmentStatusNew":null,"highestDevelopmentShortName":null,"therapeuticAreaShortName":null,"productSubType":"","amount2New":0,"dosageForm":"","sponsorNew":"Ichnos Glenmark Innovation \/ Certara","highestDevelopmentStatusID":null,"companyTruncated":"Ichnos Glenmark Innovation \/ Certara"}]
Find Clinical Drug Pipeline Developments & Deals by Ichnos Glenmark Innovation
Filters
×
FILTER:
Company Name
Year
DEALS // DEV.
Country
Sponsor
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target